CARE Tool Study Aim 3

Study summary

This study is a multi-site randomized trial to study the implementation of the CARE Tool and evaluate the CARE Tool. The CARE Tool is a web-based tool that gives people information about cancer care costs, health insurance, and resources to help with costs. Overall, the study aims to help patients with cancer overcome barriers they face navigating insurance and accessing financial resources.

Ask AI to explain this study

Start here

Key things to know

Main goalHealth Services Research

This describes the study’s primary purpose.

What is being studiedFinancial education information and CARE Tool

Plus 1 other study approaches.

Who it may be forGynecologic Cancer · Prostate Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Jul 8, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Recruiting

The study is currently accepting participants.

What kind of study?Not applicable

Interventional

Where is it offered?3 U.S. locations

Locations may change over time.

Who runs it?Washington University School of Medicine

Study sponsor

Study overview

What this study is about

Purpose: Health Services Research
Study type: Interventional
Phase: Not applicable
Sponsor: Washington University School of Medicine
Interventions being studied: Other: Financial education information; Other: CARE Tool; Other: CARE Tool Training

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

for Implementation champions: \- Members of the cancer care team (e.g., physicians, nurses, research coordinators, financial navigators, social workers) that work with patients receiving treatment for gynecologic, lung, prostate, or colorectal cancer; or members of the billing team and employee of Siteman Cancer Center, Barnes Jewish Hospital, Washington University, Delbert Day Cancer Institute at Phelps Health, or Alton Memorial Hospital

Reasons someone may not be able to joinExclusion criteria

for Implementation champions:
Implementation champions are ineligible if they are non-employees of Siteman Cancer Center, Barnes Jewish Hospital, Washington University, Delbert Day Cancer Institute at Phelps Health, or Alton Memorial Hospital
Do not treat patients for gynecologic, prostate, lung, or colorectal cancer Inclusion Criteria for Patients:
Age 18 and over
Primary or recurrent diagnosis of gynecologic, prostate, lung, or colorectal cancer in the last 12 months
Receiving cancer treatment from Siteman Cancer Center, Delbert Day Cancer Institute at Phelps Health, or Alton Memorial Hospital
Self-reported ability to read and speak English

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

Alton Memorial HospitalAlton, Illinois
Delbert Day Cancer Institute at Phelps HealthRolla, Missouri
Washington University School of MedicineSt Louis, Missouri

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jul 8, 2026. Always confirm current availability with the study team.

View original record ↗